All the news from the laboratory

  • April 2024 29 April 2024

    What do people with psychosis want in cannabis harm reduction interventions? Up to 60% of young people with psychosis uses cannabis, which is associated with significantly poorer clinical and psychosocial outcomes. While existing cannabis interventions typically focus on abstinence or reduction, effective interventions remain scarce, often hindered by low engagement or retention rates. There is a growing demand for harm…

  • March 2024 18 April 2024

    Introducing the ASCME* project  Methamphetamine use has increased considerably worldwide in recent years (1). Canada, like the rest of the world, is confronted with this problematic growth (2). Methamphetamine use is associated with significant long-term morbidity and mortality, including psychiatric, physical and social complications, placing a heavy burden on the healthcare system (3). At present, there are no pharmaceutical drugs…

  • February 2024 21 February 2024

    Reshaping Addiction Treatment: The Relevance of Non-Abstinence ApproachesThe paradigm of abstinence as the only relevant outcome in the treatment of substance use disorders has been shaken once again by the results of a study published in January 2024 in the prestigious journal Addiction. A group of researchers affiliated with the US-based Johns Hopkins university analyzed a large database of rigorously…


The laboratory of Didier Jutras-Aswad is getting attention in the media. Discover all our news coverage by clicking below.

You are from the media and would like to obtain an interview with Dr Didier Jutras-Aswad?